Unternehmen Calmare Therapeutics Incorporated Other OTC
Aktien
A12ANA
US13126R1023
CTTC
Medizinische Ausrüstung
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Conrad Mir
CEO | Chief Executive Officer | 55 | 27.09.13 |
Director of Finance/CFO | 71 | - | |
Donna Mays
ADM | Chief Administrative Officer | - | - |
Stephen D'Amato
CTO | Chief Tech/Sci/R&D Officer | - | - |
William Lipford
SAM | Sales & Marketing | - | - |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Rustin Howard
BRD | Director/Board Member | 67 | 01.10.07 |
Conrad Mir
CEO | Chief Executive Officer | 55 | 27.09.13 |
Stanley Yarbro
BRD | Director/Board Member | 74 | - |
Peter Brennan
CHM | Chairman | 69 | 06.06.11 |
Santanu Das
BRD | Director/Board Member | - | 12.07.19 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 38 997 971 | 38 997 971 ( 100,00 %) | 0 | 99,99 % |
Aktie B | 0 | 2 427 | 0 | 0 |
Unternehmenskontakt
Calmare Therapeutics, Inc.
2 Trap Falls Road Suite 507
06484, Shelton
+
http://www.calmaretherapeutics.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+7.84% | 218 Mrd. | |
+7.35% | 184 Mrd. | |
+13.04% | 135 Mrd. | |
-1.33% | 62.38 Mrd. | |
+11.80% | 51.37 Mrd. | |
+4.81% | 50.9 Mrd. | |
+0.30% | 40.87 Mrd. | |
+2.78% | 36.28 Mrd. | |
+26.14% | 31.88 Mrd. |